Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about EXCITOTOXICITY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | EXCITOTOXICITY |
| Key Genes/Proteins | AKT, AMPK, AMYLOID, AMYLOID-BETA, amyotrophic lateral sclerosis |
| Related Diseases | ALS, Alzheimer'S Disease, ALZHEIMER'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS |
Knowledge base pages for this entity
graph TD
EXCITOTOXICITY["EXCITOTOXICITY"]
EXCITOTOXICITY -->|"causes"| Neurotoxicity["Neurotoxicity"]
EXCITOTOXICITY -->|"causes"| STIM1["STIM1"]
EXCITOTOXICITY -->|"causes"| NEURODEGENERATION["NEURODEGENERATION"]
EXCITOTOXICITY -->|"inhibits"| FOXO3["FOXO3"]
EXCITOTOXICITY -->|"activates"| NEURON["NEURON"]
EXCITOTOXICITY -->|"activates"| STING["STING"]
EXCITOTOXICITY -->|"promotes"| HIPPOCAMPUS["HIPPOCAMPUS"]
EXCITOTOXICITY -->|"promotes"| OXIDATIVE_STRESS["OXIDATIVE STRESS"]
EXCITOTOXICITY -->|"regulates"| MITOCHONDRIAL_DYSFUNCTION["MITOCHONDRIAL DYSFUNCTION"]
glutamate_receptors["glutamate receptors"] -->|"causes"| EXCITOTOXICITY
Glutamate["Glutamate"] -->|"causes"| EXCITOTOXICITY
Glutamate_receptors["Glutamate receptors"] -->|"mediates"| EXCITOTOXICITY
NAD_metabolism["NAD metabolism"] -->|"participates in"| EXCITOTOXICITY
GLUTAMATE["GLUTAMATE"] -->|"causes"| EXCITOTOXICITY
glutamate["glutamate"] -->|"causes"| EXCITOTOXICITY
ginsenosides["ginsenosides"] -->|"inhibits"| EXCITOTOXICITY
inflammation["inflammation"] -->|"causes"| EXCITOTOXICITY
GLUTAMATE_RECEPTORS["GLUTAMATE_RECEPTORS"] -->|"causes"| EXCITOTOXICITY| Target | Relation | Type | Str |
|---|---|---|---|
| Neurotoxicity | causes | process | 0.90 |
| Calcium Overload | associated_with | process | 0.90 |
| Stroke | contributes_to | disease | 0.90 |
| Motor Neuron Death | causes | process | 0.90 |
| Ischemic Stroke | contributes_to | disease | 0.90 |
| Motor Neuron Degeneration | contributes_to | phenotype | 0.85 |
| Ferroptosis | activates | pathway | 0.70 |
| ERK | regulates | gene | 0.70 |
| Amyotrophic lateral sclerosis | associated_with | disease | 0.70 |
| CELL DEATH | activates | phenotype | 0.70 |
| FERROPTOSIS | inhibits | phenotype | 0.65 |
| FERROPTOSIS | activates | phenotype | 0.65 |
| FERROPTOSIS | targets | phenotype | 0.65 |
| AMPK | activates | gene | 0.65 |
| UBIQUITIN | degrades | protein | 0.65 |
| NECROPTOSIS | activates | phenotype | 0.65 |
| AXONAL DEGENERATION | activates | phenotype | 0.65 |
| NECROPTOSIS | regulates | phenotype | 0.65 |
| FERROPTOSIS | causes | phenotype | 0.65 |
| STIM1 | causes | protein | 0.64 |
| MIRO1 | associated_with | gene | 0.60 |
| SST | activates | gene | 0.60 |
| STIM1 | activates | gene | 0.60 |
| neuroinflammation | associated_with | process | 0.60 |
| oxidative stress | regulates | process | 0.60 |
| TRKB | associated_with | gene | 0.60 |
| TET2 | activates | gene | 0.55 |
| VGLUT1 | inhibits | gene | 0.55 |
| HK2 | activates | gene | 0.55 |
| TFEB | activates | gene | 0.55 |
| ULK1 | activates | gene | 0.55 |
| PARKINSON'S DISEASE | participates_in | disease | 0.55 |
| SPINAL CORD | associated_with | brain_region | 0.55 |
| PROTEIN AGGREGATION | associated_with | process | 0.50 |
| GABA | co_discussed | entity | 0.50 |
| GABAergic | co_discussed | entity | 0.50 |
| INFLAMMASOME | co_discussed | entity | 0.50 |
| NLRP3 | co_discussed | entity | 0.50 |
| NMDA | co_discussed | entity | 0.50 |
| MLKL | co_discussed | entity | 0.50 |
| NECROPTOSIS | co_discussed | entity | 0.50 |
| PSD95 | co_discussed | entity | 0.50 |
| MS | co_discussed | entity | 0.50 |
| NEURON | causes | entity | 0.50 |
| RIPK1 | co_discussed | entity | 0.50 |
| RIPK3 | co_discussed | entity | 0.50 |
| LOCUS COERULEUS | co_discussed | entity | 0.50 |
| GLUTAMATE | co_discussed | entity | 0.50 |
| NEURODEGENERATION | co_discussed | entity | 0.50 |
| FOXO3 | co_discussed | entity | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| NPY | protects_against | protein | 0.95 |
| Oligodendrocyte | mediates | cell_type | 0.90 |
| Astrocyte | mediates | cell_type | 0.90 |
| 39602529 | were neuroprotective against | paper | 0.90 |
| glutamate receptors | causes | protein | 0.90 |
| Glutamate receptors | mediates | receptor | 0.90 |
| Glutamate | causes | entity | 0.90 |
| Glutamate Receptor Accumulation | contributes_to | process | 0.85 |
| CYTOKINES | associated_with | protein | 0.85 |
| Astrocytes | contributes_to | cell_type | 0.85 |
| Glutamate Receptor Accumulation | causes | mechanism | 0.85 |
| NAD metabolism | participates_in | biological_process | 0.80 |
| SOD1 | mediates | protein | 0.80 |
| NPY | alleviates | gene | 0.80 |
| HMGCR | inhibits | gene | 0.80 |
| GLUTAMATE | causes | drug | 0.72 |
| glutamate | causes | protein | 0.70 |
| TREM2 upregulation in DAM cells | causes | mechanism | 0.70 |
| VGLUT1 terminals | vulnerable_to | cell_type | 0.70 |
| SYNAPTIC PLASTICITY | causes | phenotype | 0.70 |
| NPTX2 downregulation | causes | mechanism | 0.70 |
| inflammation | causes | process | 0.70 |
| GABA | protects_against | phenotype | 0.70 |
| GABA | inhibits | phenotype | 0.70 |
| SLC7A11 | causes | protein | 0.70 |
| ginsenosides | inhibits | drug | 0.70 |
| glutamate_receptors | causes | protein | 0.68 |
| GLUTAMATE_RECEPTORS | causes | protein | 0.68 |
| ASTROCYTES | exacerbates | cell_type | 0.65 |
| STROKE | causes | disease | 0.65 |
| ALZHEIMER'S DISEASE | implicated_in | disease | 0.65 |
| BDNF | activates | gene | 0.65 |
| LOCUS COERULEUS | causes | brain_region | 0.65 |
| ROS | inhibits | phenotype | 0.65 |
| ASTROCYTE | causes | cell_type | 0.65 |
| KYNURENINE PATHWAY | activates | pathway | 0.65 |
| SLC1A2 | protects_against | gene | 0.60 |
| SLC1A3 | protects_against | gene | 0.60 |
| AKT | activates | gene | 0.58 |
| ALZHEIMER'S DISEASE | activates | disease | 0.58 |
| GABA | expressed_in | phenotype | 0.55 |
| GLUTAMATE | associated_with | phenotype | 0.55 |
| autophagy | activates | pathway | 0.55 |
| SYNAPSE | associated_with | concept | 0.50 |
| DOPAMINERGIC | co_discussed | entity | 0.50 |
| CDK5 | co_discussed | entity | 0.50 |
| Neurodegeneration | associated_with | disease | 0.50 |
| amyotrophic lateral sclerosis | associated_with | gene | 0.50 |
| MOTOR NEURON | activates | concept | 0.50 |
| NEURONS | activates | concept | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Subtle NMDAR Inhibition Attenuates Excitotoxicity-Driven Tau | 0.620 | neurodegeneration | Investigate prion-like spreading of tau |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-18 | 4 hypotheses Top: 0.538
neurodegeneration | 2026-04-16 | 7 hypotheses Top: 0.680
neurodegeneration | 2026-04-16 | 0 hypotheses
neurodegeneration | 2026-04-10 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 0 · Score: 0.66 · 2026-04-21
closed · Rounds: 0 · Score: 0.64 · 2026-04-21
closed · Rounds: 4 · Score: 0.30 · 2026-04-21
closed · Rounds: 4 · Score: 0.50 · 2026-04-18
closed · Rounds: 5 · Score: 0.59 · 2026-04-16
closed · Rounds: 4 · Score: 0.70 · 2026-04-16
Hypotheses and analyses mentioning EXCITOTOXICITY in their description or question text
No additional research found